Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study
| Autor: | Ashley K Clift, David A Harrison, Ian D. Pavord, Min Gao, Jamie Hartmann-Boyce, Nicola Lindson, Pui San Tan, Julia Hippisley-Cox, Doug W Gould, Paul Aveyard, Duncan Young, Carol Coupland, Peter J. Watkinson |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
Pulmonary and Respiratory Medicine medicine.medical_specialty Population Comorbidity Risk Assessment law.invention Pulmonary Disease Chronic Obstructive 03 medical and health sciences COVID-19 Testing 0302 clinical medicine Adrenal Cortex Hormones law Administration Inhalation medicine Humans 030212 general & internal medicine Mortality education Asthma COPD education.field_of_study SARS-CoV-2 business.industry Public health COVID-19 Articles Middle Aged medicine.disease Intensive care unit Hospitalization Intensive Care Units England Social Class 030228 respiratory system Cohort Emergency medicine Female Risk assessment business |
| Zdroj: | The Lancet. Respiratory Medicine |
| ISSN: | 2213-2600 |
| Popis: | Background Previous studies suggested that the prevalence of chronic respiratory disease in patients hospitalised with COVID-19 was lower than its prevalence in the general population. The aim of this study was to assess whether chronic lung disease or use of inhaled corticosteroids (ICS) affects the risk of contracting severe COVID-19. Methods In this population cohort study, records from 1205 general practices in England that contribute to the QResearch database were linked to Public Health England's database of SARS-CoV-2 testing and English hospital admissions, intensive care unit (ICU) admissions, and deaths for COVID-19. All patients aged 20 years and older who were registered with one of the 1205 general practices on Jan 24, 2020, were included in this study. With Cox regression, we examined the risks of COVID-19-related hospitalisation, admission to ICU, and death in relation to respiratory disease and use of ICS, adjusting for demographic and socioeconomic status and comorbidities associated with severe COVID-19. Findings Between Jan 24 and April 30, 2020, 8 256 161 people were included in the cohort and observed, of whom 14 479 (0·2%) were admitted to hospital with COVID-19, 1542 ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|